Medical Dialogues

T2D, Obesity and Heart Failure: Breaking the Pathophysiologic Triangle

India's diabetes burden has risen markedly, with 101 million individuals living with diabetes1. The clinical burden is ...

Why stopping GLP-1 drugs may undo weight loss and heart gains

People who quit taking popular GLP-1 drugs such as Ozempic might their jeopardize heart health, according to a new study.

You Can Have a Normal Weight and Still Be at Risk for Heart Failure

Research Highlights Fat stored around the waist, often called belly fat or visceral fat, showed a much stronger link to heart ...

New study identifies how obesity-related liver cancer becomes more aggressive and resistant to treatment

A research team affiliated with UNIST has made a significant discovery explaining why liver cancers associated with obesity and metabolic disorders tend to be more aggressive and less responsive to ...

Linking adiposity and inflammation with all-cause and cardiovascular mortality

Life's Essential 8 (LE8) and Life's Crucial 9 (LC9) from the American Heart Association are industry-accepted metrics that summarize overall cardiovascular health. A new study documents inverse ...

Obesity Treatment Is Evolving And It’s No Longer Just About Weight Loss

Obesity is not just about weight gain. Experts explain why improving metabolic health is key to reducing risks like diabetes, heart disease, and fatty liver.

This metric is a better predictor of heart failure than high BMI, new study finds

Researchers found that having higher levels of fat stored around the abdomen was more strongly associated with heart failure risk than a high bodyweight or BMI, according to an ab ...

Think it’s just breathlessness? The American Heart Association’s new guidelines warn pulmonary embolism can turn fatal fast: Doctors explain what you need to know

The American Heart Association (AHA) and the American College of Cardiology (ACC) have recently released the first guideline for acute pulmonary embol.